INZY   $5.95  2.50% Market Open

Inozyme Pharma Inc
Total Cash 144.52M
totalCashPerShare 2.304
EBITDA -92.10M
Total Debt 46.71M
quickRatio 9.299
currentRatio 9.842
Total Revenue
debtToEquity 49.47
Revenue/Share
ROA -0.37866002
ROE -0.88556
grossProfits
freeCashflow -55.05M
operatingCashflow -85.55M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 278.59M
forwardPE -3.585366
floatShares 35.02M
sharesOutstanding 67.10M
sharesShort 3.98M
sharesShortPriorMonth 4.16M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.98%
Short Ratio help_outline 12.60%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 1.521
Price To Book help_outline 3.87
earningsQuarterlyGrowth
netIncomeToCommon -88.56M
trailingEps -1.44%
forwardEps -1.64%
enterpriseToEbitda -3.02
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.44 3Q 2024
institutionsCount 125
lastUpdated Sept. 16, 2024, 7:58 p.m.